MK0966, rofecoxib
MK0966, rofecoxib is a pharmaceutical drug with 10 clinical trials. Historical success rate of 80.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
8 of 10 finished
20.0%
2 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)
A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)
A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)
Clinical Trials (10)
A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)
A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)
A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)
A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10